Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein

Journal of Immunological Methods

Volumn 197, Issue 1-2, 1996, Pages 7-18

  Buratti, E ^a   Tisminetzky, S G ^a   Scodeller, E S ^a   Baralle, F E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

epitope presentation; HIV 1 gp41 epitope; monoclonal antibody; solid phase peptide binding assay

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 41; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ANTIGEN PRESENTATION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INSECT VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

FLOCK HOUSE VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INSECTA; MIRIDAE;

EID: 0030590639     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(96)00097-X     Document Type: Article

References (35)

1. Blum, P., Velugan, M., Lin, N. and Matin, A. (1992) DnaK-mediated alterations in human growth hormone protein inclusion bodies. Bio/technology 10, 301-304.
2. Brochier, B., Kieny, M.P., Costy, F., Coppens, P., Bauduin, B., Lecocq, J.P., Languet, B., Chappuis, G., Desmettre, P., Afiademanyo, K. et al. (1991) Large scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 354, 520-522.
3. Brown, A.L., Francis, M.J., Hasting, Z.C., Parry, N.R., Barnett, P.V., Rowlands, D.J. and Clarke, B.E. (1991) Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine 9, 595-601.
4. Dorow, D.S., Shi, P.T., Carbone, F.R., Minasian, E., Todd, P.E. and Leach, S.J. (1985) Two large immunogenic and antigenic myoglobulin peptides and the effects of cyclisation. Mol. Immunol. 22, 1255-1264.
5. Dreesman, G.R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J.T., Six, H.R., Peterson, D.L., Hollinger, F.B. and Melnick, J.L. (1982) Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature 295, 158-160.
6. Evans, D.J., McKeating, J., Meredith, J.M., Burke, K.L., Katrak, K., John, A., Ferguson, M., Minor, P.D., Weiss, R.A. and Almond, J.W. (1989) An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385-388.
7. Fisher, A.J., McKinney, B.R., Schneemann, A., Rueckert, R.R. and Johnson, J.E. (1993) Crystallization of virus like particles assembled from Flock House virus coat protein expressed in a baculovirus system. J. Virol. 67, 2950-2953.
8. Friede, M., Muller, S., Briand, J.P., Plauè, S., Fernandes, I., Frisch, B., Schuber, F. and Van Regenmortel, M.H.V. (1994) Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes. Vaccine 12 791-797.
9. Ghiara, J.B., Stura, E.A., Stanfield, R.L., Profy, A.T. and Wilson, I.A. (1994) Crystal structure of the principal neutralization site of HIV-1, Science 264, 83-85.
10. Halsey, N.A., Markham, R., Wahren, B., Boulos, R., Rossi, P. and Wigzell, H. (1992) Lack of association between maternal antibodies to V3 loops peptides and maternal-infant HIV-1 transmission. J. Acquired Immune Defic. Syndr. 5, 153-157.
11. Hattori, K., Angel, P., Le Beau, M.M. and Karin, M. (1988) Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc. Natl. Acad. Sci. USA 85, 9148-9152.
12. Hubscher, U. (1987) Double replica southwestern. Nucleic Acids Res. 15, 5486.
13. Kennedy, R.C., Henkel, R.D., Puletti, D., Allan, J.S., Lee, T.H., Essex, M. and Dressman, G.R. (1986) Antiserum to a synthetic peptide recognises HTLV-III envelope glycoprotein. Science 231, 1556-1559.
14. Landschultz, W.H., Johnson, P.F. and McKnight, S.L. (1988) The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240, 1759-1764.
15. Levy, J. (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289.
16. McAleer, W.J., Buynak, E.B., Maigetter, R.Z., Wampler, D.E., Miller, W.J. and Hilleman, M.R. (1984) Human hepatitis B vaccine from recombinant yeast. Nature 307, 178-180.
17. McGrew, B.R. and MacDonald Green, D. (1990) Enhanced removal of detergent and recovery of enzymatic activity following sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem. 189, 68-74.
18. Mohammed, K. and Esen, A. (1989) A blocking agent and a blocking step are not needed in ELISA, immunostaining dotblots and Western blots. J. Immunol. Methods 117, 141-145.
19. Moore, J.P. (1993) The reactivities of HIV-1 + human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules. AIDS Res. Hum. Retroviruses 9, 209-217.
20. Moore, J.P., Cao, Y., Conley, A.J., Wyatt, R., Robinson, J., Gorny, M.K., Zolla-Pazner, S., Ho, D.D. and Koup, R.A. (1994) Studies with monoclonal antibodies to the V3 region of HIV-1 gp-120 reveal limitations to the utility of solid-phase peptide binding assays. J. Acquired Immune Defic. Syndr. 7, 332-339.
21. Muller, S., Plaue, S., Samama, J.P., Valette, M., Briand, J.P. and Van Regenmortel, M.H. (1990) Antigenic properties and protective capacity of a cyclic peptide corresponding to a site A of influenza virus haemagglutinin. Vaccine 8, 308-314.
22. Muster, M., Ferko, B., Klima, A., Purtscher, P., Trkola, A., Schulz, P., Grassauer, A., Engelhardt, O.G., Garcia-Sastre, A., Palese, P. and Katinger, H. (1995) Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J. Virol. 69, 6678-6686.
23. O'Shea, E.K., Rutkowski, R. and Kim, P.S. (1989) Evidence that the leucine zipper is a coiled coil. Science 243, 538-542.
24. Ossipow, V., Laemmli, U. and Schibler, U. (1993) A simple method to renature DNA-binding proteins separated by SDS-polyacrylamide gel electrophoresis. Nucleic Acids Res. 21, 6040-6041.
25. Pincus, S.H., Messer, K.G., Schwartz, D.H., Lewis, G.K., Graham, B.S., Blattner, W.A. and Fisher, G. (1993) Difference in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. J. Clin. Invest. 91, 1987-1996.
26. Riley, L.G., Junius, F.K., Swanton, M.K., Vesper, N.A., Williams, N.K., King, G.F. and Weiss, A.S. (1994) Cloning, expression, and spectroscopic studies of the Jun leucine zipper domain. Eur. J. Biochem. 219, 877-886.
27. Sattentau, Q.J., Zolla Pazner, S. and Poignard, P. (1995) Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206, 713-717.
28. Schutten, M., Langedijk, J.P.M., Andeweg, A.C., Huisman, R.C., Meloen, R.H. and Osterhaus, A.D.M.E. (1995) Characterization of V3 domain specific neutralizing human mAb that preferentially recognizes non-syncytium-inducing HIV-1 strains. J. Gen. Virol. 76, 1665-1673.
29. Scodeller, E.A., Tisminetzky, S.G., Porro, F., Schiappacassi, M., De Rossi, A., Chiecco-Bianchi, L. and Baralle, F.E. (1995) A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies. Vaccine 13, 1233-1239.
30. Tisminetzky, S.G., Scodeller, E.A., Evangelisti, P., Chen, Y., Schiappacassi, M., Porro, F., Bizik, F., Zacchi, T., Lunazzi, G., Miertus, S. and Baralle, F.E. (1994) Immunoreactivity of chimeric proteins carrying the HIV-1 epitope IGPGRAF. Correlation between predicted conformation and antigenicity. FEBS Lett. 353, 1-4.
31. Tsoukas, C.M. and Bernard, N.F. (1994) Markers predicting progression of human immunodeficiency virus-related desease. Clin. Microbiol. Rev. 7, 14-28.
32. Vella, C., Minor, P.D., Weller, I.V.D., Jenkins, O., Evans, D. and Almond, J. (1991) Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection. AIDS 5, 425-430.
33. Vella, C., Ferguson, M., Dunn, G., Meloen, R., Langedijk, H., Evans, D. and Minor, P.D. (1993) Characterization and primary structure of a HIV-1 neutralization domain as presented by a poliovirus tipe 1/HIV-1 chimera. J. Gen. Virol. 74, 2603-2607.
34. Weiss, R.A. (1993) How does HIV cause AIDS. Science 260, 1273-1279.
35. Zanetti, M. (1992) Antigenized antibodies. Nature 355, 476-477.